AbbVie is buying a biotech company working on an experimental eczema drug for $10.9 billion
Apogee Therapeutics is developing a promising atopic dermatitis drug.
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
TORONTO, ON / ACCESS Newswire / June 22, 2026 /Adcore Inc. (TSX:ADCO)(OTCQX:ADCOF)(FSE:ADQ) ("Adcore" or the "Company"), a global leader in AI marketing te...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesApogee Therapeutics is developing a promising atopic dermatitis drug.
Quantum BioPharma stock surges on MS imaging study progress
Theriva Biologics stock surges on AACR cancer trial data
Alamar Biosciences IPO expected to price at top of range or above
Todd Blanche Named Interim U.S. Attorney General The post Crypto Enforcement Architect Todd Blanche Named Interim Attorney General appeared first on Crypto...
BTIG downgrades Zimmer Biomet, sees limited upside amid growth challenges
This experimental pill helped people lose about 16% of their body weight after about a year of treatment
Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for biotech companies.
Agilent to acquire Biocare Medical in $950 million all-cash deal
The company has performed well over the long run.
Roivant, Arbutus Biopharma stocks surges on $2.25B Moderna settlement
This biotech powerhouse could maintain its strength for the long term.